Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com        SPECIAL REPORT #21.4   Oncology Drug Approvals in 2021   Each year in January, Bruno Pagliara, an oncology specialist, publishes in MedNous, a review where he comments the yearly oncology regulatory approvals. The number of oncology drug approvals in 2021,  in the four […]

  Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com      SPECIAL REPORT #22.3   Digest of the 2022 JPMorgan Healthcare Conference   The 40th JPMorgan Annual Health Care Conference took place virtually on January 10-13, 2022. This yearly conference is the largest health care investment symposium in the biopharmaceutical industry which connects global industry […]

Next Bio-Europe Spring  is approching and you already know that You have only limited time to prepare the business convention.  We can design together mission that meet you needs: – Preparation (in total or partially): screening potential customers, partners for your technology or therapeutic molecules to license or your services to promote – Representation: Meeting […]

You plan to increase your footpring on new territories in EU or US market ? to launch a new technology, a service or product on the market ? You look for partners to license your product or technology to pharma & biotech companies Let's meet at BIOTECHGATE DIGITAL PARTNERING FEB 7-11 ! Please send me […]

  Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com        SPECIAL REPORT #22.2     U.S. FDA approves 63 new treatments in 2021   In 2021, the U.S. FDA has approved 50 new treatment options through the Center for Drug Evaluation and Research (CDER) and 13 new Biological License Application (BLA) approvals through […]